Aurinia Pharmaceuticals Inc Stock News

In a report released today, Alethia Young from Cantor Fitzgerald reiterated a Buy rating on Gilead Sciences ( GILD – Research Report ), with a price target of $86.00 . The company’s shares closed

Franklin Resources Inc. lessened its holdings in shares of Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) (TSE:AUP) by 5.6% during the 4th quarter, according to its most recent disclosure with the SEC. The

venBio Closes $394 Million Life Sciences Venture Capital Fund, Bringing Total Assets Under Management to Nearly $1 Billion

Q4 2019 Aurinia Pharmaceuticals Inc Earnings Call

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Aurinia Pharmaceuticals (AUPH), BerGenBio AS (BRRGF) and

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Aurinia Pharmaceuticals

In a report issued on March 27, Alethia Young from Cantor Fitzgerald reiterated a Buy rating on Stemline Therapeutics ( STML – Research Report ), with a price target of $10.00 . The company’s shar

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Biocept (BIOC), Becton Dickinson (BDX) and Aurinia

While the event was changed from an in-person format to a digital event due to concerns of the coronavirus (COVID-19), the Foundation and its advocates did not let that deter them from their mission.

Wall Street pros recommend making an investment decision based on multiple factors rather than just a single metric like fundamentals.

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Entasis Therapeutics Holdings (ETTX) and Zynerba